Clinical trials: Inhaled Corticosteroid

Asthma

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

• Completed
• Age: 6 to 17 years
• Phase 4
• Results posted

The purpose of this trial is to compare the efficacy of 4 to 5 months of three treatments - omalizumab, corticosteroid therapy boost, and placebo - in reducing fall exacerbations in inner-city children and adolescents with…

Trial name

PROSE (NCT01430403)

Testing

Omalizumab, Inhaled Corticosteroid Boost Therapy (ICS)

Where

8 sites in United States

Volunteers

478 people

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)